News
Novo Nordisk's Wegovy Weight-Loss Drug Sales Surge Despite Copycat Issues — Update
Semaglutide--which is marketed as Wegovy for weight-loss and Ozempic for diabetes--had been in short supply as the company raced to increase production and meet surging demand. But the drug came off the shortage list earlier this year and the FDA had told anyone distributing copies of the injections that they must stop by the end of May.
It’s the most high-profile example yet of a controversial industry practice called preferred pharmacy networks, or PPNs ...
The National Institute for Health and Care Excellence (Nice) is concerned about the number of people regaining weight after ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
The celebrity chef, 59, told how he's been taking the slimming aid to help combat the effects of his bipolar medication, ...
Indian pharmaceutical companies are preparing to launch generic versions of Novo Nordisk's weight-loss drug, semaglutide, potentially reducing its price by up to 80%.
Novo Nordisk’s weight loss drug, Wegovy, is experiencing a surge in new prescriptions following a US ban on its copycat ...
Money Talks News on MSN1h
Your Wegovy Access Just Changed: What Patients Need to Know Now
Novo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback